These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1334584)
1. Serial interleukin-6 blood levels early after cardiac transplantation. Weyand M; Krehmeier M; Fahrenkamp A; Middendorf C; Redmann M; Schwartz C; Konertz W; Scheld HH Transplant Proc; 1992 Dec; 24(6):2546. PubMed ID: 1334584 [No Abstract] [Full Text] [Related]
2. Cytomegalovirus infection in liver transplantation: graft infection and clinical relevance. Sido B; Hofmann WJ; Otto G; Amann K; Arnold JC; Herfarth C Transplant Proc; 1992 Dec; 24(6):2641-2. PubMed ID: 1334592 [No Abstract] [Full Text] [Related]
3. Cytomegalovirus surveillance following liver transplantation: does it allow presymptomatic diagnosis of cytomegalovirus disease? Umana JP; Mutimer DJ; Shaw JC; McLeish PJ; Buchan A; Martin B; Neuberger JM; Elias E; McMaster P Transplant Proc; 1992 Dec; 24(6):2643-5. PubMed ID: 1334593 [No Abstract] [Full Text] [Related]
4. Increased late rejection in cytomegalovirus-immunoglobulin-M-positive heart transplantation patients. Bunke M; Ganzel B; Gardner C Transplant Proc; 1995 Oct; 27(5 Suppl 1):44-5. PubMed ID: 7482819 [No Abstract] [Full Text] [Related]
5. Evolution and significance of Toxoplasma gondii antibody titers in kidney transplant recipients. Renoult E; Biava MF; Aimone-Gastin I; Aouragh F; Hestin D; Kures L; Kessler M Transplant Proc; 1992 Dec; 24(6):2754-5. PubMed ID: 1465928 [No Abstract] [Full Text] [Related]
6. Preliminary evidence that monitoring of plasma granulocyte-macrophage colony-stimulating factor may be helpful to differentiate between infection and rejection in renal transplant patients. Daniel V; Pasker S; Reiss U; Weimer R; Pomer S; Staehler G; Opelz G Transplant Proc; 1992 Dec; 24(6):2770-2. PubMed ID: 1334598 [No Abstract] [Full Text] [Related]
7. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514 [TBL] [Abstract][Full Text] [Related]
9. Current experience with renal transplantation across the ABO blood group barrier. Bryan CF; Nelson PW; Aeder MI; Beck ML; Helling TS; Hughes TM; Luger AM; Pierce GE; Shield CF Transplant Proc; 1992 Dec; 24(6):2527-9. PubMed ID: 1465854 [No Abstract] [Full Text] [Related]
10. Cytomegalovirus infection and the development of cellular rejection. Fyfe AI J Heart Lung Transplant; 1994; 13(2):343. PubMed ID: 8031820 [No Abstract] [Full Text] [Related]
11. Diagnosis of viral infections under therapy with OKT3 and antithymocyte globulin. Müller T; Sprenger H; Keuchel M; Neumann C; Ebel H; Gemsa D; Lange H Transplant Proc; 1992 Dec; 24(6):2636-8. PubMed ID: 1334590 [No Abstract] [Full Text] [Related]
12. [Cytomegalovirus infection and coronary sclerosis after heart transplantation]. Loebe M; Schüler S; Spiegelsberger S; Warnecke H; Fleck E; Hetzer R Dtsch Med Wochenschr; 1990 Aug; 115(34):1266-9. PubMed ID: 2167829 [TBL] [Abstract][Full Text] [Related]
13. [Cytomegalovirus (CMV) infection: a frequent and life-threatening complication in heart transplant patients]. Mohacsi P; Leonardi L; Waser M; Lüthy A; Laske A; Turina M; Gallino A Ther Umsch; 1990 Feb; 47(2):157-63. PubMed ID: 2156344 [TBL] [Abstract][Full Text] [Related]
14. Analysis of CD45RA- CD45RO+ "memory" T cells in patients after kidney, heart, and liver transplantation. Winkler M; Schwinzer R; Wonigeit K; Ringe B; Pichlmayr R Transplant Proc; 1992 Dec; 24(6):2532-4. PubMed ID: 1465856 [No Abstract] [Full Text] [Related]
15. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation. Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172 [TBL] [Abstract][Full Text] [Related]
16. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients. George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720 [TBL] [Abstract][Full Text] [Related]
17. Incidence of symptomatic viral infections in children and adolescents after renal transplantation. Korn K; Ruder H; Stenglein S; Gheith S Transplant Proc; 1992 Dec; 24(6):2639-40. PubMed ID: 1334591 [No Abstract] [Full Text] [Related]
18. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients. Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850 [No Abstract] [Full Text] [Related]
19. What are the implications of cardiac infection with cytomegalovirus before heart transplantation? Lowry RW; Adam E; Hu C; Kleiman NS; Cocanougher B; Windsor N; Bitar JN; Melnick JL; Young JB J Heart Lung Transplant; 1994; 13(1 Pt 1):122-8. PubMed ID: 8167117 [TBL] [Abstract][Full Text] [Related]
20. [Identification of DNA of cytomegalovirus, its antibodies and viral antigens in patients after organ transplantation]. Dolgikh MS; Vediakov AM; Feoktistova EIu; Adueva SM; Makarova NE; Kushch AA; Pustovoĭt B Biull Eksp Biol Med; 1999 May; 127(5):560-3. PubMed ID: 10399583 [No Abstract] [Full Text] [Related] [Next] [New Search]